Work

HMBG-1 and other soluble factors in HIV-1 pathogenesis

Year: 2009
Type: dissertation
Abstract: The innate immune system is the first defense mechanism invading \npathogens encounter. Macrophages, dendritic cells and \ncytokines/chemokines are important factors for the functionality of the \ninnate immunity, and provide the adaptive immune system with sufficient \nsignals for the proper action. Immune activation occurring during HIV-1 \ninfection is essential to understand and investigate. \n \n \n \nThe aims of this thesis were to evaluate the role of immune activation \nfactors of the innate immune system, such as cytokines and chemokines, in \ndifferent sets of patient categories, cellular systems and phases during \nthe HIV-1 infection. We were most interested in a particular cytokine, \nthe high mobility group box protein 1 (HMGB1). In addition to our in \nvitro experiments, we had access to an unique cohort, the Quest study, \nwhich is the first placebo controlled treatment trial in acute HIV-1 \ninfection. For our substudy, we selected 22 patients, categorized into \nresponders and non-responders regarding the outcome of their viral load \nafter analytical treatment interruption (ATI). We found that high levels \nof immune activation as determined by the pattern of cytokines/chemokines \nduring PHI, did not favor a better virological outcome after ATI. The \nearly initiation of ART did not seem to affect the preservation of the \nimmune system. \n \n \n \nHMGB1 is a proinflammatory cytokine, ubiquitously expressed in all \nnucleated cells, with a functional importance as a regulator of \ntranscription and stabilization of the nucleosomal structure. HMGB1 is \nactively secreted from LPS- or TNF-activated macrophages/monocytes, \npituicytes and other cells. HMGB1 can also be passively released by \ndamaged necrotic or apoptotic cells. We studied the role of HGMB1 in \ndifferent systems and modes during HIV-1 infection. Extracellular HMGB1 \nupregulated HIV-1 infection in latently infected U1 monocytic cells, but \ndid not have impact on viral replication in ACH-2 Tlymphocytic cells. In \nacute HIV-1 infected monocyte-derived macrophages (MDMs), HIV-1 \nproduction was downregulated, most likely due to the increased production \nof the chemokines MIP-1alpha, MIP-1beta and Rantes. Furthermore, higher \nlevels of HMGB1 were found in HIV-1 infected patients with deteriorated \nimmune status and opportunistic conditions, compared to uninfected \nindividuals and HIV-1 infected patients with less preserved immune \nstatus. Additionally, HMGB1 was released by HIV-1 infected MT4 cells and \nCD4+ T-cells, in connection with virus induced cell death. This release \ncould be interfered by addition of a pan-caspase inhibitor Z-vad to MT4 \ncells cultures. We suggest that HMGB1 was released passively from MT4 \ncells not only during necrosis but also during apoptosis. \n \n \n \nIn conclusion, the presented data cast a light on the importance of the \nimmune activation process during HIV-1 pathogenesis. HMGB1 is released \nduring the viral cell infection and may be a molecule connecting the cell \ndeath processes and the immune activation during HIV-1 infection.
Source: Figshare
Language: English
Subfield: Virology
Open Access status: green
OpenAlex ID: W2134945328
Cites: 214
Cited by:
Related to: 10